Continuum Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Continuum Advisory's VRTX Position: Q2 2026 in Review
Continuum Advisory reduced its Vertex Pharmaceuticals (VRTX) stake by 2.9% in Q2 2026, selling an estimated $8.86K and leaving 665 shares worth $330K. The position accounts for 0.03% of the portfolio, ranked #374.
Continuum Advisory first reported a position in VRTX in Q3 2022 and has held it in 16 quarters since. The position peaked at $807K in Q1 2025. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Continuum Advisory held 665 shares of Vertex Pharmaceuticals worth $330K as of Q2 2026.
- Continuum Advisory sold 20 Vertex Pharmaceuticals shares in Q2 2026, an estimated $8.86K.
- Vertex Pharmaceuticals made up 0.03% of Continuum Advisory's portfolio in Q2 2026, its #374 holding.
- Continuum Advisory first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
- Continuum Advisory's Vertex Pharmaceuticals position peaked at $807K in Q1 2025.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.